Most patients in the control group received other GLP-1 drugs such as semaglutide, which Novo Nordisk sells for diabetes as ...

Widespread brain inflammation diminishes over time in Long COVID, shifting the clinical focus to emotional regulation.

Given that nearly everyone in the United States is believed to have had COVID, the 16 percent rate extrapolated to the ...

Surpass-Early randomized ~800 adults with ≤4-year type 2 diabetes on metformin to add tirzepatide or intensify care, predominantly with semaglutide or dulaglutide comparators. At two years, ...

A total of 16.28% of patients with COVID-19 have developed postacute sequelae (PASC), or long-term symptoms that develop weeks or months after an infection. That is according to a May investigation ...

Patients with systemic autoimmune rheumatic disease demonstrate an increased persistence of SARS-CoV-2 antigen positivity up ...

A possible first case of COVID recurrence after ensitrelvir: a vaccinated woman whose antigen levels fall and then rebound, with symptoms returning 1 day after treatment.

A Mount Sinai-led research team has demonstrated that autoimmunity, in which the body's immune system attacks its own tissues, is responsible for the often-debilitating and confounding symptoms of ...

In January 2021, at the height of the pandemic, Sharon Charlebois spent three weeks at the Civic hospital battling a life-threatening case of COVID-19.

The ICU Bed Act is bipartisan and proven to work. The next health crisis will not wait, and neither should Congress. Lives ...

Doctors across India are reporting a worrying rise in hip damage among younger adults after the COVID-19 pandemic. Experts say delayed diagnosis, sedentary lifestyles, and excessive steroid use during ...

Long COVID is a serious, growing public health crisis. Though estimates vary, as many as 18 million Americans may be affected. This is why it continues to capture the attention of Senator Todd Young, ...